| 1 Woche | 1 Monat | 3 Monate | Lfd. Jahr | 1 Jahr | 3 Jahre | |
| Kurs | 15,766 € | 15,268 € | 13,904 € | 13,836 € | 10,5238 € | 17,9795 € |
| Änderung | -6,43% | -3,38% | +6,10% | +6,62% | +40,18% | -17,95% |
| Zeit | Titel | Quelle |
| 05.01.26 | Protalix BioTherapeutics Letter to Stockholders | PR Newswire |
| 13.11.25 | Protalix BioTherapeutics Reports Third Quarter 2025 Financial and Business Results | PR Newswire |
| 14.08.25 | Protalix BioTherapeutics Reports Second Quarter 2025 Financial and Business Results | PR Newswire |
| 07.08.25 | Protalix BioTherapeutics to Announce Second Quarter 2025 Financial and Business Results on August 14, 2025 | PR Newswire |
| 30.06.25 | Protalix BioTherapeutics Added to Russell 3000® and 2000 Indexes® | PR Newswire |
| 14.05.25 | Protalix BioTherapeutics to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference at Nasdaq NYC | PR Newswire |
| Kaufen | Halten | Verkaufen | |
|---|---|---|---|
| Analysten | 0 | 0 | 0 |
| Markt-Lotsen | 0 | 0 | 0 |
